TriStem

The TriStem Group has been set up by Mr.Ghazi Dhoot and Dr. Ilham Saleh Abuljadayel to further research and develop its retrodifferentiation technology which is used to create stem cells from mature adult cells. The retrodifferentiation technology is based on the results of 12 years of research and currently TriStem is the only company that owns, and is in the process of commercialising, this technology. The main advantage of TriStem's new process over existing methods of harvesting stem cells is that it provides large quantities of stem cells which are by definition DNA matched and, therefore, bypasses the political and ethical issues concerned with therapeutic cloning.

Contact Details: 571, Finchley Road,Unit 320 London London NW3 7BN United Kingdom Tel: Fax: Email: info@tristemcorp.com WWW: www.tristemcorp.com/

Loading...

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 349 times since April 2007, the link to the organisation's website has been followed 115 times

Recent Search Terms used to find this page: Tristem Technologies | Tristem Technologies london | Induction of stem cell-like plasticity in mononuclear cells derived from unmobilised adult human peripheral blood | Retrodifferentiated Stem Cells | TriStem UK Limited | tristem | tristem | 571 Finchley Road Unit 320 London NW3 7BN | Tristem uk | retrodifferentiation technology | .

Search for more companies in London

Search for more companies in London

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for TriStem